Polymorphism C in the serotonin transporter gene (SLC6A4) in questionable dementia and Alzheimer's disease

Neurosci Lett. 2008 Jun 27;438(3):335-9. doi: 10.1016/j.neulet.2008.04.076. Epub 2008 Apr 25.

Abstract

The promoter region of the serotonin transporter gene (SLC6A4) shows a 22-bp tandem repeat polymorphism, indicated as polymorphism C, that has been associated to depression, obsessive-compulsive disorder, memory impairment, and anxiety. Less clear are data regarding its association with Alzheimer's disease (AD). No data were reported regarding its association with questionable dementia (QD). In this study we investigate for polymorphism C in the SLC6A4 gene 302 elderly subjects with a clinical diagnosis of AD (n=105), QD (n=88) and no cognitive impairment (n=114) attending a geriatric ward. A community-dwelling sample of 390 healthy subjects was also included in the analysis. A significant higher prevalence of the C16/C16 genotype in AD than in QD was observed (37.14% vs. 3%; p=0.041, OR 2.001, 95%CI 1.018-4.024), while no differences in the C16/C14 and C14/C14 genotypes as well as in the estimated allele frequencies were found. No further differences among the three groups of subjects were found, also when they were compared with the community-dwelling sample. These findings suggest that SLC6A4 gene variation may have only a minor role, if any, in AD or QD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / genetics*
  • Dementia / diagnosis
  • Dementia / genetics*
  • Female
  • Gene Frequency
  • Genetic Predisposition to Disease*
  • Genotype
  • Humans
  • Male
  • Polymorphism, Genetic*
  • Retrospective Studies
  • Serotonin Plasma Membrane Transport Proteins / genetics*
  • Statistics, Nonparametric
  • Tandem Repeat Sequences / genetics

Substances

  • SLC6A4 protein, human
  • Serotonin Plasma Membrane Transport Proteins